AIP NEWS

Advanced Innovative Partners Receives Orphan Drug and Rare Pediatric Disease Designation from the FDA for Aromatic L-Amino Acid Decarboxylase.

Aromatic L-Amino Acid Decarboxylase

Advanced Innovative Partners Receives Orphan Drug and Rare Pediatric Disease Designation from the FDA for Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia

Advanced Innovative Partners Receives Orphan Drug and Rare Pediatric Disease Designation from the FDA for Acute Radiation Syndrome

Acute Radiation Syndrome

Advanced Innovative Partners Receives Orphan Drug and Rare Pediatric Disease Designation from the FDA for Atypical Teratoid Rhabdoid Tumors

Atypical Teratoid Rhabdoid Tumors

Advanced Innovative Partners Receives Orphan Drug and Rare Pediatric Disease Designation from the FDA for Diffuse Intrinsic Pontine Glioma

Diffuse Intrinsic Pontine Glioma

Advanced Innovative Partners Receives Orphan Dug and Rare Pediatric Disease Designation from the FDA for Hepatoblastoma

Hepatoblastoma

Advanced Innovative Partners Receives Orphan Dug and Rare Pediatric Disease Designation from the FDA for Lesch-Nyhan Syndrome

Lesch-Nyhan Syndrome

Advanced Innovative Partners Receives Orphan Drug and Rare Pediatric Disease Designation from the FDA for Medulloblastoma

Medulloblastoma

© Copyright 2023 - All Rights Reserved